Last reviewed · How we verify
TD0019 oral capsule
TD0019 oral capsule is a Small molecule drug developed by Sao Thai Duong Joint Stock Company. It is currently in Phase 2 development. Also known as: Vien Vai Gay Thai Duong.
At a glance
| Generic name | TD0019 oral capsule |
|---|---|
| Also known as | Vien Vai Gay Thai Duong |
| Sponsor | Sao Thai Duong Joint Stock Company |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TD0019 oral capsule CI brief — competitive landscape report
- TD0019 oral capsule updates RSS · CI watch RSS
- Sao Thai Duong Joint Stock Company portfolio CI
Frequently asked questions about TD0019 oral capsule
What is TD0019 oral capsule?
TD0019 oral capsule is a Small molecule drug developed by Sao Thai Duong Joint Stock Company.
Who makes TD0019 oral capsule?
TD0019 oral capsule is developed by Sao Thai Duong Joint Stock Company (see full Sao Thai Duong Joint Stock Company pipeline at /company/sao-thai-duong-joint-stock-company).
Is TD0019 oral capsule also known as anything else?
TD0019 oral capsule is also known as Vien Vai Gay Thai Duong.
What development phase is TD0019 oral capsule in?
TD0019 oral capsule is in Phase 2.
Related
- Manufacturer: Sao Thai Duong Joint Stock Company — full pipeline
- Also known as: Vien Vai Gay Thai Duong
- Compare: TD0019 oral capsule vs similar drugs
- Pricing: TD0019 oral capsule cost, discount & access